BMJ  2007;334:274 (10 February), doi:10.1136/bmj.39115.419236.1F

Letters

Animal testing

Studies in animals should be more like those in humans

The first 100% of the full text of this article appears below.

The settings of animal studies are very different from those of therapeutic studies in human patients.1 They need to be more similar.

In clinical studies a human subjects committee must approve the methods of the study, determining that it is of sufficient power to produce a meaningful result and that the risk:benefit ratio is acceptable. There should be animal subject committees similarly to scrutinise drug trials in animals. The task of such committees would be to assess sample size, randomisation of treatments, blinding of observers, selection of animal subjects, statistical methods, and elimination of biases that may be introduced by the pharmaceutical company that sponsors the work.

Alexander S D Spiers, retired professor of medicine

1 Cookham Dean, Berkshire spiersuk@btinternet.com


Competing interests: None declared.

  1. Hackam DG. Translating animal research into clinical benefit. BMJ 2007;334:163-4. (27 January.)[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Translating animal research into clinical benefit
Daniel G Hackam
BMJ 2007 334: 163-164. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ